Tobias Klatte

24PUBLICATIONS
53CO-AUTHORS
Haematological tumoursCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Feb 26, 2026
Impact of BCG failure patterns on efficacy of intravesical gemcitabine/docetaxel in high-risk non-muscle-invasive bladder cancer.

Pietro Scilipoti, Paolo Zaurito, Mattia Longoni

|Jan 28, 2026
Trends in the Management of Bladder Cancer with Emphasis on Frailty: A Nationwide Analysis of More Than 49,000 Patients from a German Hospital Network.

Tobias Klatte, Frederic Bold, Julius Dengler

|Jan 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results.

Pietro Scilipoti, Mattia Longoni, Mario de Angelis

|Nov 14, 2024
Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder.

Kira Furlano, Henning Plage, Sebastian Hofbauer

|Jun 16, 2023
Effect of smoking, hypertension and lifestyle factors on kidney cancer - perspectives for prevention and screening programmes.

Riccardo Campi, Giacomo Rebez, Tobias Klatte

|May 13, 2023
The Allium Ureteral Stent for the Treatment of Ureteral Complications Following Renal Transplantation-A Single-Center, Single-Surgeon Series.

Sarah Weinberger, Mandy Hubatsch, Tobias Klatte

Pageof 4

Frequent Collaborators

8 joint publications

Grant D Stewart

5 joint publications

Sabrina H Rossi

4 joint publications

Umberto Capitanio

3 joint publications

Riccardo Campi